From: Emerging nanobiotechnology for precise theranostics of hepatocellular carcinoma
Nanocarriers | Diagnostic Agent | Technique | Target cell | References |
---|---|---|---|---|
Nanobubbles (NBs) | Nanobubbles; Pro-bexarotene NBs; NBs-GPC3-rGO; Poly(oxalate-co-curcumin) (POC) | Ultrasound imaging; Nano-knife | HCC cell lines, HepG2 | |
Dendrimer | Polydopamine | CT and PTT | HepG2 | |
Carbon Dots (CDs) | Gd | MRI | HepG2 | [58] |
Calcium phosphate NPs | Gd-DTPA | MRI | BEL-7402,HepG2 | [59] |
Silica NPs | Gd; Gold NPs | MRI and PDT | BNL 1 ME A. 7R.1 cell | |
Graphene Oxide-Based Nanocarriers | Gd | MRI | Human hepatoma cells | |
Metal oxide NPs (Iron, Zinc) | Gd | MRI | HepG2 | |
Superparamagnetic Iron-Oxide NPs(SPIONs) | Gd; Iron oxide | MRI | HCC cell lines | |
Micelles | Micelles; SPION; Gd | MRI/UCL | HepG2 | |
Lipid NPs; Vesicle NPs; Liposome | Gd; Quantum dots | MRI/PAI | HepG2 | |
Polymeric NPs | Gd-DTPA; SPION | MRI | HCC cell lines |